DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market by Offering, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013 - 2023" report has been added to ResearchAndMarkets.com's offering.
Based on offering, the oligonucleotide synthesis market is classified into synthesized oligonucleotides, reagents and consumables, and equipment. During the historical period, synthesized oligonucleotides held the largest share in the market, accounting for 76.3% in 2017.
Based on application, the oligonucleotide synthesis market is categorized into research, diagnostics, and therapeutics. Of these, the fastest growth in the market during the forecast period is expected from research applications, with a CAGR of 11.1%.
On the basis of end user, the market is categorized into academic research institutes, diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Others primarily include food and beverage companies and forensic laboratories. Academic research institutes are expected to continue holding the largest share in the oligonucleotide synthesis market in the coming years. They accounted for 40.4% share in the market in 2017.
Geographically, North America held the largest share in oligonucleotide synthesis, with 39.1% contribution in 2017. This can be attributed to technological advancements, favorable government regulations, and high incidence of infectious diseases in the region.
During the forecast period, the oligonucleotide synthesis market is projected to witness the fastest growth in APAC, with a CAGR of 11.6%. The market growth in the region can be attributed to improving healthcare infrastructure, increasing need for better health outcomes, and rising prevalence of chronic and infectious diseases.
Key Topics Covered:
Chapter 1. Research Background
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Introduction
Chapter 5. Global Market Size And Forecast
Chapter 6. North America Market Size And Forecast
Chapter 7. Europe Market Size And Forecast
Chapter 8. APAC Market Size And Forecast
Chapter 9. LATAM Market Size And Forecast
Chapter 10. MEA Market Size And Forecast
Chapter 11. Competitive Landscape
Chapter 12. Company Profiles
- Eurofins Scientific SE
- LGC Limited
- Danaher Corporation
- GeneDesign Inc.
- Maravai LifeSciences Inc.
- Kaneka Eurogentec S.A.
- General Electric Company
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Genscript Biotech Corporation
For more information about this report visit https://www.researchandmarkets.com/research/rbrlh2/oligonucleotide?w=4
